Instrument Inactif

Communiqués Flamel Technologies S.A. (ADR) Nasdaq

Actions

US3384881096

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

27/06	Avadel Pharmaceuticals rejoindra l'indice Russell 3000 lundi ; les actions augmentent après les heures d'ouverture	MT
12/06	Transcript : Avadel Pharmaceuticals plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 03:20 PM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Avadel Pharmaceuticals to Join Russell 3000 Index	28/06	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	30/05	AQ
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024	22/05	AQ
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors	21/05	AQ
Avadel: Q1 Earnings Snapshot	08/05	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial Results	08/05	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8	01/05	AQ
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference	01/04	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	05/03	AQ
Avadel Pharmaceuticals Issues Statement On Patent Litigation	04/03	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	04/03	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4	26/02	AQ
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02	AQ
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights	08/01	AQ
Avadel: Q3 Earnings Snapshot	08/11	AQ
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results	08/11	AQ
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences	07/11	AQ
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8	30/10/23	AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ for extended-release oral suspension at World Sleep 2023	23/10/23	AQ
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023	20/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Flamel Technologies S.A. (ADR) Nasdaq

Actions

US3384881096

Communiqués

Filtres